Cronos Group CEO Mike Gorenstein on Tuesday said the company would expand to the US within the next year.
Bank of America Merrill Lynch upgraded the stock to "buy" from "underperform."
Shares were up more than 15%.
Watch Cronos trade live.
Cronos Grou soared more than 15% Wednesday after the Canadian cannabis company announced it plans to launch cannabidiol, or CBD, in the US within the next six to 12 months.
Following the announcement, Bank of America Merrill Lynch gave...
Read this story at Business Insider